OPTH
Optimi Health Corp.
There isn't enough reported data to score OPTH yet.
OPTH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
OPTH's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
OPTH PE Valuation
OPTH has no meaningful PE right now: it lost money over the past year.
OPTH Forward outlook
There aren't enough analyst estimates for OPTH to show an outlook.
OPTH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2023 | -$1.31 | +$1.32 |
| Q1 2023 | -$1.31 | +$1.61 |
| Q4 2022 | -$1.55 | +$1.18 |
| Q3 2022 | -$2.12 | +$0.02 |
OPTH is still losing money, but far less than before: $1.37 per share over the past year, against $2.92 at its worst in early 2022.
OPTH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $98.7K | -29% |
| Q1 2026 | $70K | +62% |
| Q2 2025 | $138.1K | +58% |
| Q1 2025 | $43.1K | -26% |
| Q4 2024 | $163.6K | +121% |
| Q3 2024 | $40.7K | +190% |
| Q2 2024 | $87.2K | +185% |
| Q1 2024 | $58.3K | +18% |
OPTH's revenue has slid since its 2024 peak: $98,700 last quarter, down 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1523% | -1116 points |
| Q1 2026 | -1364% | +251 points |
| Q2 2025 | -406% | +445 points |
| Q1 2025 | -1615% | +11 points |
| Q4 2024 | -498% | +602 points |
| Q3 2024 | -2744% | +3779 points |
| Q2 2024 | -851% | +2101 points |
| Q1 2024 | -1626% | -1626 points |
OPTH's operating margin was −1523% last quarter, down 1025 points from the same quarter a year ago.
OPTH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2M | -$1.4M |
| Q1 2026 | -$242.3K | -$188.7K |
| Q4 2025 | -$449.9K | -$217.4K |
| Q3 2025 | -$1M | -$462.4K |
| Q2 2025 | -$603.5K | +$137K |
| Q1 2025 | -$53.6K | +$472.8K |
| Q4 2024 | -$232.5K | +$1.1M |
| Q3 2024 | -$557.6K | +$363.3K |
OPTH has burned cash in almost every quarter: −$4M over the past year, against −$1M the year before.
OPTH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +33% | +1.1M shares |
| 1 year | +33% | +1.1M shares |
| 3 years | +84% | +2M shares |
OPTH has 4M diluted shares, up 33% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
OPTH hasn't bought back shares in the past year.
OPTH Net Leverage
OPTH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OPTH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.5 | Oversold |
| Stochastic | 11.4 | Oversold |
OPTH's weekly RSI is 27 (oversold) and its Stochastic is 11 (oversold).
OPTH PE vs Healthcare Sector
OPTH has no meaningful PE right now: it lost money over the past year.
OPTH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 35% below |
| 20 week MA | $4.24 | 49% below |
| 50 week MA | $5.63 | 61% below |
| 100 week MA | $5.22 | 58% below |
OPTH is in a downtrend: it's below all four of its weekly moving averages, and 58% below its 100-week average.
OPTH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $7.20 | $4.70 | -35% |
| 2025 | $4.70 | $7.26 | +54% |
| 2026 YTD | $7.26 | $2.18 | -70% |
OPTH has finished lower in one of the last two years. It's down 70% so far in 2026.